Feasibility research of enhanced recovery after surgery implemented in esophageal cancer patients who underwent neoadjuvant chemotherapy
Abstract Background Enhanced recovery after surgery (ERAS) is a perioperative management protocol to accelerate patient recovery. This study aimed to evaluate the feasibility of ERAS protocols implemented in patients who underwent neoadjuvant chemotherapy (NACT) before minimally invasive McKeown eso...
Main Authors: | Zhanpeng Tang, Xirui Zhu, Yanzhi Li, Chenghao Qu, Lin Li, Shuhai Li, Lei Qi, Ming Lu, Chuanle Cheng, Hui Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-022-02701-3 |
Similar Items
-
Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
by: Chengzhi Ding, et al.
Published: (2023-12-01) -
Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: A retrospective study
by: Fan Yu, et al.
Published: (2022-12-01) -
Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
by: Guozhen Yang, et al.
Published: (2023-06-01) -
Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer
by: Sicong Hou, et al.
Published: (2021-10-01) -
Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
by: Zhao J, et al.
Published: (2023-08-01)